York Instruments acquires Elekta’s MEG business

Smith & Williamson has advised York Instruments, a UK company specializing in healthcare applications, on its acquisition of the magnetoencephalography business (MEG) of Elekta AB.
15 Jul 2018
DealRoom
Authors
  • DealRoom
Gettyimages 697853664 WEB

Smith & Williamson advises York Instruments, LLC (“York Instruments”) on its acquisition of the magnetoencephalography business (“MEG Business”) of Elekta AB (“Elekta”).

MEG is a diagnostic functional neuroimaging technique for mapping brain activity. This can be applied in a clinical setting to find locations of abnormalities as well as in a research setting to simply measure brain activity. Elekta’s MEG business, known as MEGIN, is a leading supplier of magnetoencephalography (MEG) technology, with more than 100 delivered MEG systems worldwide.

York Instruments is a UK-based company specializing in magnetic measurements and their healthcare applications. Using the very latest technologies and methodologies, York Instruments is focused on magnetoencephalography (MEG) and its ability to effectively assess neural networks. York Instruments' revolutionary MEG technology allows for earlier and improved diagnostic capability in relation to a variety of neurological diseases and conditions.

Gordon Baltzer, CEO of York Instruments, said: “The combination of Elekta’s experience and York Instruments’ advanced technology provides an exciting new future for MEG. We look forward to serving Elekta’s current customers and expanding the MEG market beyond its current borders.”
Brian Livingston, Managing Director of Smith & Williamson Corporate Finance said: “We are delighted to have completed this international acquisition which further builds upon Oaklins credentials in the manufacturing and medical equipment sectors”.

Disclaimer
By necessity, this briefing can only provide a short overview and it is essential to seek professional advice before applying the contents of this article. No responsibility can be taken for any loss arising from action taken or refrained from on the basis of this publication. Details correct at time of writing.

Note to editors
Smith & Williamson is an independently owned professional and financial services group with over 1,700 people. The group is a leading provider of investment management, financial advisory and accountancy services to private clients, professional practices and mid-to-large corporates. The group has eleven offices; these are in London, Belfast, Birmingham, Bristol, Dublin (City and Sandyford), Glasgow, Guildford, Jersey, Salisbury and Southampton.

Smith & Williamson Corporate Finance Limited
Authorised and regulated by the Financial Conduct Authority. A member of Oaklins International Inc. For legal notices, please refer www.oaklins.com/legal.

Disclaimer

This article was previously published on Smith & Williamson prior to the launch of Evelyn Partners.